NanoVibronix Inc (NASDAQ:NAOV) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 81,100 shares, an increase of 37.2% from the August 31st total of 59,100 shares. Based on an average trading volume of 3,830,000 shares, the short-interest ratio is currently 0.0 days.
NASDAQ:NAOV traded up $0.02 on Thursday, reaching $0.72. The company’s stock had a trading volume of 374,904 shares, compared to its average volume of 1,568,304. NanoVibronix has a 1-year low of $0.54 and a 1-year high of $3.50. The firm has a market cap of $3.59 million, a PE ratio of -1.15 and a beta of -0.43. The business’s 50-day moving average price is $0.83 and its two-hundred day moving average price is $1.74.
NanoVibronix (NASDAQ:NAOV) last posted its quarterly earnings data on Wednesday, August 19th. The company reported ($0.20) earnings per share for the quarter. The firm had revenue of $0.27 million for the quarter. NanoVibronix had a negative return on equity of 537.97% and a negative net margin of 771.63%. As a group, equities research analysts forecast that NanoVibronix will post -0.81 earnings per share for the current fiscal year.
NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing.
Featured Story: Analyst Ratings Trading
Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.